251 related articles for article (PubMed ID: 31552188)
1. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.
Amantini C; Morelli MB; Nabissi M; Piva F; Marinelli O; Maggi F; Bianchi F; Bittoni A; Berardi R; Giampieri R; Santoni G
Front Oncol; 2019; 9():874. PubMed ID: 31552188
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study.
Lee HS; Jung EH; Shin H; Park CS; Park SB; Jung DE; Leem G; Kim SJ; Jo JH; Chung MJ; Park JY; Bang S; Park SW; Song SY
Front Oncol; 2023; 13():1206565. PubMed ID: 37736542
[TBL] [Abstract][Full Text] [Related]
4. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice.
Zhao X; Ma Y; Dong X; Zhang Z; Tian X; Zhao X; Yang Y
Hepatobiliary Surg Nutr; 2021 Dec; 10(6):796-810. PubMed ID: 35004946
[TBL] [Abstract][Full Text] [Related]
6. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma.
Kim H; Heo CM; Oh J; Chung HH; Lee EM; Park J; Lee SH; Lee KH; Lee KT; Lee JK; Cho YK; Park JK
Transl Oncol; 2022 Feb; 16():101321. PubMed ID: 34954457
[TBL] [Abstract][Full Text] [Related]
8. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
[No Abstract] [Full Text] [Related]
9. The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis.
Tang HD; Wang Y; Xie P; Tan SY; Li HF; Shen H; Zhang Z; Lei ZQ; Zhou JH
Front Genet; 2022; 13():892177. PubMed ID: 35754798
[TBL] [Abstract][Full Text] [Related]
10. A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal Adenocarcinoma.
Javed AA; Floortje van Oosten A; Habib JR; Hasanain A; Kinny-Köster B; Gemenetzis G; Groot VP; Ding D; Cameron JL; Lafaro KJ; Burns WR; Burkhart RA; Yu J; He J; Wolfgang CL
Ann Surg; 2023 Jun; 277(6):866-872. PubMed ID: 36111839
[TBL] [Abstract][Full Text] [Related]
11. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
15. Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker.
Song BG; Kwon W; Kim H; Lee EM; Han YM; Kim H; Byun Y; Lee KB; Lee KH; Lee KT; Lee JK; Jang JY; Park JK
Front Oncol; 2020; 10():616440. PubMed ID: 33680936
[TBL] [Abstract][Full Text] [Related]
16. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
[TBL] [Abstract][Full Text] [Related]
17. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.
Wei T; Zhang X; Zhang Q; Yang J; Chen Q; Wang J; Li X; Chen J; Ma T; Li G; Gao S; Lou J; Que R; Wang Y; Dang X; Zheng L; Liang T; Bai X
Cancer Lett; 2019 Jun; 452():237-243. PubMed ID: 30905814
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer.
Zhu L; Hissa B; Győrffy B; Jann JC; Yang C; Reissfelder C; Schölch S
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429174
[TBL] [Abstract][Full Text] [Related]
20. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
